Genentech (NYSE:DNA) formerly known as (NYSE:GNE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genentech (NYSE:DNA) formerly known as (NYSE:GNE)

DNA 8.870

+2.1%

Jan 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: DewDiligence_on_SI	10/10/2005 5:45:04 PM
	Read Replies (1) of 250

Lucentis update: BLA will be submitted in 12/05. It will include two-year MARINA (minimally-classic/occult) data and one-year ANCHOR (predominantly-classic) data. MARINA data update: 75% and 71% of patients in the low and high-dose arms, respectively, had some gain in VA relative to baseline at one year, vs only 26% of patients on placebo. [Source: DNA CC in progress.]

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next